Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Graphene cellulose hybrids for biodegradable flexible sensing devices.

Discover nano·2026
Same author

Antibacterial ZnO nanoparticle embedded polycaprolactone-polyhydroxybutyrate membranes for wound healing.

Journal of materials science. Materials in medicine·2026
Same author

Translating Innovation Into Practice: Dissemination of Immune Checkpoint Inhibitors and Their Toxicity Management Across the Globe.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting·2026
Same author

A multifunctional conductive physiomimetic scaffold: synergy of rGO coating and cannabis-derived nanotopography for infection-resistant bone repair.

Frontiers in bioengineering and biotechnology·2026
Same author

Design, Synthesis, and Characterization of <i>N</i>‑Doped Carbon Dots from a Ternary System of Citric Acid, Urea, and (<i>E</i>)‑2-(2,5-Dimethoxyphenyl)methylenebutane-1,4-dioic Acid.

ACS omega·2026
Same author

Corrigendum for "Engineered core-shell nanocomposite fibres incorporating bio-ceramics and bioactive molecules for wound repair" [Int. J. Pharm. 690 (2026) 126533].

International journal of pharmaceutics·2026

Related Experiment Video

Updated: Jun 18, 2026

Manufacture and Drug Delivery Applications of Silk Nanoparticles
09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

15.9K

Nanoparticles: Taking a Unique Position in Medicine.

Tomy Muringayil Joseph1, Debarshi Kar Mahapatra2, Amin Esmaeili3

  • 1Department of Polymer Technology, Faculty of Chemistry, Gdańsk University of Technology, G. Narutowicza, 80-233 Gdańsk, Poland.

Nanomaterials (Basel, Switzerland)
|February 11, 2023
PubMed
Summary

Nanotechnology (NT) offers significant advances in medicine, with nanomaterials (NMs) revolutionizing drug delivery and diagnostics. Further research into nanoparticle (NP) toxicity is crucial for safe and effective clinical applications.

Keywords:
biomaterialsbiomedicaldiagnosismedicinenanomaterialsnanoparticlespharmaceuticals

More Related Videos

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

9.0K
Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy
05:06

Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy

Published on: November 10, 2023

1.0K

Related Experiment Videos

Last Updated: Jun 18, 2026

Manufacture and Drug Delivery Applications of Silk Nanoparticles
09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

15.9K
A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

9.0K
Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy
05:06

Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy

Published on: November 10, 2023

1.0K

Area of Science:

  • Biomedicine and Pharmaceutical Sciences
  • Nanotechnology applications in healthcare

Background:

  • Human curiosity has driven scientific inquiry throughout history.
  • Recent advancements in nanotechnology (NT) are transforming medicine and drug development.
  • Nanomaterials (NMs) are increasingly vital in clinical applications, from imaging to targeted drug delivery.

Purpose of the Study:

  • To highlight the significant contributions of nanoparticles (NPs) to modern medicine and drug delivery.
  • To explore the potential future impact of nanotechnology in medicine and pharmaceuticals.
  • To emphasize the need for understanding NP toxicity for safe clinical translation.

Main Methods:

  • Review of current literature on nanotechnology in medicine and drug delivery.
  • Analysis of the role of nanomaterials in diagnostics and therapeutics.
  • Discussion of the challenges and future directions of NP applications.

Main Results:

  • Nanoparticles (NPs) enable advanced diagnostics and therapies, including targeted drug and gene delivery.
  • NMs are essential in modern medicine, serving as contrast agents and drug carriers.
  • The clinical application of NPs presents unique environmental and societal challenges, particularly regarding toxicity.

Conclusions:

  • Nanotechnology holds immense promise for revolutionizing disease diagnosis, treatment, and prevention.
  • A deeper understanding of NP pathophysiology is essential for developing sophisticated diagnostic tools and effective therapies.
  • Continued research balancing innovation with safety is critical for realizing the full potential of NT in medicine.